Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 5777-5786, December 15, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miccoli, L.
Right arrow Articles by Poupon, M.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miccoli, L.
Right arrow Articles by Poupon, M.-F.

Light-induced Photoactivation of Hypericin Affects the Energy Metabolism of Human Glioma Cells by Inhibiting Hexokinase Bound to Mitochondria1

Laurent Miccoli, Arnaud Beurdeley-Thomas, Gonzague De Pinieux, Franck Sureau, Stéphane Oudard, Bernard Dutrillaux and Marie-France Poupon2

Laboratoire de Cytogénétique Moléculaire et Oncologie, CNRS UMR 147, Institut Curie, 75248 Paris Cedex 05, France [L. M., A. B-T., G. D-P., S. O., B. D., M-F. P.], and Laboratoire de Physico-Chimie Biomoléculaire et Cellulaire, CNRS URA 2056, Université Pierre et Marie Curie, 75252 Paris Cedex 05, France [F. S.]

Glucose-dependent energy required for glioma metabolism depends on hexokinase, which is mainly bound to mitochondria. A decrease in intracellular pH leads to a release of hexokinase-binding, which in turn decreases glucose phosphorylation, ATP content, and cell proliferation. Thus, intracellular pH might be a target for therapy of gliomas, and a search for agents able to modulate intracellular pH was initiated. Hypericin, a natural photosensitizer, displays numerous biological activities when exposed to light. Its mechanism and site of action at the cellular level remain unclear, but it probably acts by a type II oxygen-dependent photosensitization mechanism producing singlet oxygen. Hypericin is also able to induce a photogenerated intracellular pH drop, which could constitute an alternative mechanism of hypericin action. In human glioma cells treated for 1 h with 2.5 µg/ml hypericin, light exposure induced a fall in intracellular pH. In these conditions, mitochondria-bound hexokinase was inhibited in a light- and dose-dependent manner, associated with a decreased ATP content, a decrease of mitochondrial transmembrane potential, and a depletion of intracellular glutathione. Hexokinase protein was effectively released from mitochondria, as measured by an ELISA using a specific anti-hexokinase antibody. In addition to decreased glutathione, a response to oxidative stress was confirmed by the concomitant increase in mRNA expression of {gamma}-glutamyl cysteine synthetase, which catalyzes the rate-limiting step in overall glutathione biosynthesis, and is subject to feedback regulation by glutathione. Hypericin also induced a dose- and light-dependent inhibition of [3H]thymidine uptake and induced apoptosis, as demonstrated by annexin V-FITC binding and cell morphology. This study confirmed the mitochondria as a primary target of photodynamic action. The multifaceted action of hypericin involves the alteration of mitochondria-bound hexokinase, initiating a cascade of events that converge to alter the energy metabolism of glioma cells and their survival. In view of the complex mechanism of action of hypericin, further exploration is warranted in a perspective of its clinical application as a potential phototoxic agent in the treatment of glioma tumors.

1 This work was supported by grants from the Ligue Nationale Contre le Cancer (Comités de Moselle et National) and from the Association pour la Recherche sur le Cancer.

2 To whom requests for reprints should be addressed, at CNRS UMR 147, Institut Curie, 26, rue d'Ulm, 75248 Paris Cedex 05, France. Phone: 33 1 42 34 66 67; Fax: 33 1 42 34 66 14; E-mail: mfpoupon@curie.fr.

Received 7/31/98. Accepted 10/15/98.




This article has been cited by other articles:


Home page
The OncologistHome page
M. S. Ricci and W.-X. Zong
Chemotherapeutic approaches for targeting cell death pathways.
Oncologist, April 1, 2006; 11(4): 342 - 357.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
W.-X. Zong and C. B. Thompson
Necrotic death as a cell fate.
Genes & Dev., January 1, 2006; 20(1): 1 - 15.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Chauvin, S. Salhi, C. Le Goff, W. Viranaicken, D. Diop, and O. Jean-Jean
Involvement of Human Release Factors eRF3a and eRF3b in Translation Termination and Regulation of the Termination Complex Formation
Mol. Cell. Biol., July 15, 2005; 25(14): 5801 - 5811.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Lavastre, M. Pelletier, R. Saller, K. Hostanska, and D. Girard
Mechanisms Involved in Spontaneous and Viscum album Agglutinin-I-Induced Human Neutrophil Apoptosis: Viscum album Agglutinin-I Accelerates the Loss of Antiapoptotic Mcl-1 Expression and the Degradation of Cytoskeletal Paxillin and Vimentin Proteins Via Caspases
J. Immunol., February 1, 2002; 168(3): 1419 - 1427.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.